PriceTargets.com logo

NantHealth - NH Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.34 As of 04/18/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for NH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NantHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NH

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for NantHealth in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.34.

This chart shows the closing price for NH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in NantHealth. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/7/2022The Goldman Sachs GroupUpgradeNeutral ➝ BuyLow
8/26/2019CowenSet TargetBuy$1.00Low
(Data available from 4/18/2019 forward)

News Sentiment Rating

0.48 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
9/21/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/21/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/20/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
12/20/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
1/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/18/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/18/2024

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

NantHealth logo
NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.
Read More

Today's Range

Now: $0.34
Low: $0.34
High: $0.34

50 Day Range

MA: $0.39
Low: $0.25
High: $0.69

52 Week Range

Now: $0.34
Low: $1.24
High: $9.75

Volume

1 shs

Average Volume

38,073 shs

Market Capitalization

$2.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Frequently Asked Questions

What sell-side analysts currently cover shares of NantHealth?

The following sell-side analysts have issued research reports on NantHealth in the last year: StockNews.com.
View the latest analyst ratings for NH.

What is the current price target for NantHealth?

0 Wall Street analysts have set twelve-month price targets for NantHealth in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for NantHealth in the next year.
View the latest price targets for NH.

What is the current consensus analyst rating for NantHealth?

NantHealth currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NH.

What other companies compete with NantHealth?

Other companies that are similar to NantHealth include Gamida Cell, Novan, Zhongchao, Agile Therapeutics and Quoin Pharmaceuticals. Learn More about companies similar to NantHealth.

How do I contact NantHealth's investor relations team?

NantHealth's physical mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company's listed phone number is (855) 949-6268 and its investor relations email address is [email protected]. The official website for NantHealth is www.nanthealth.com. Learn More about contacing NantHealth investor relations.